Approximately 10-15% of new mothers suffer from post-partum depression every year, with limited treatment options available. Will the development of a novel drug inspired by the active compound in “magic mushrooms” provide a major breakthrough? Once a favorite of the legendary psychedelic chemist Sasha Shulgin, 4-OH-DiPT could provide much needed relief from post-partum depression. Today, biotech firms, women’s health advocates, and psychedelic VC investors are collaborating with the goal of taking a closely related yet novel psychedelic compound through clinical trials for FDA approval.